Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.

Description

Currently, an immense amount of trade secrets valued at trillions of dollars are at risk of being leaked or stolen by employees, partners, and competitors. A report from The Economist Intelligence Unit in 2021 indicated that the financial implications of these vulnerabilities have soared to $1.7 trillion each year, with expectations that such risks will continue to rise in the future. Despite this alarming trend, many companies are falling short in adapting to the constantly changing legal landscape. Tangibly aims to significantly mitigate the risks associated with sharing sensitive information by offering a thorough, court-admissible record of access to your most important assets. Designed with user-friendliness in mind, the platform also includes straightforward training modules to ensure that employees, partners, and contractors can achieve compliance with minimal effort. When assets are shared through Tangibly, the software efficiently captures the required acknowledgments, regulates file access, and initiates comprehensive logging of interactions. This approach not only enhances security but also fosters a culture of accountability among those who handle sensitive information.

API Access

Has API No 

API Access

Has API No 

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial No 
Free Version No 

Pricing Details

No price information available.
Free Trial No 
Free Version No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Customer Support

Business Hours No 
Live Rep (24/7) No 
Online Support Yes 

Customer Support

Business Hours No 
Live Rep (24/7) No 
Online Support Yes 

Types of Training

Training Docs Yes 
Webinars Yes 
Live Training (Online) No 
In Person Yes 

Types of Training

Training Docs No 
Webinars No 
Live Training (Online) Yes 
In Person No 

Vendor Details

Company Name

Atomwise

Founded

2012

Country

United States

Website

www.atomwise.com

Vendor Details

Company Name

Tangibly

Founded

2021

Country

United States

Website

www.tangibly.com/tangibly-manage/

Product Features

Product Features

Compliance

Archiving & Retention No 
Artificial Intelligence (AI) No 
Audit Management No 
Compliance Tracking No 
Controls Testing No 
Environmental Compliance No 
FDA Compliance No 
HIPAA Compliance No 
ISO Compliance No 
Incident Management No 
OSHA Compliance No 
Risk Management No 
Sarbanes-Oxley Compliance No 
Surveys & Feedback No 
Version Control No 
Workflow / Process Automation No 

Alternatives

Alternatives

StarDrop Reviews

StarDrop

Optibrium
Charles River IMS Reviews

Charles River IMS

Charles River
AIDDISON Reviews

AIDDISON

Merck KGaA